Résumé Contexte Les idiopathic inflammatory demyelinating disease (IIDD) correspondent
aux scléroses en plaques explosives et/ou pseudotumorales, encéphalomyélites aiguës …

Background They are severe inflammatory demyelinating diseases of the central nervous
system, often called idiopathic inflammatory demyelinating disease (IIDD). These diseases …

Résumé La sclérose en plaques (SEP) et les pathologies du spectre de la neuromyélite
optique (NMO) sont responsables de la survenue de poussées cliniques. Ces poussées …

Résumé Les maladies inflammatoires aiguës démyélinisantes du système nerveux central
sont dominées par les formes de sclérose en plaques (SEP) dites de Marburg et …

Background: Intravenous methylprednisolone (IVMP) has been shown to hasten recovery
from attacks of multiple sclerosis (MS) without altering the long term evolution of the …

Objectives Serum synaptic proteins levels may change with age‐related neurodegeneration,
affecting their clinical implications as a disease biomarker. We aimed to investigate neuronal …

Introduction Les échanges plasmatiques (EP) font de plus en plus partie de l'arsenal
thérapeutique en neurologie, notamment dans la prise en charge des pathologies …

Plasma and CSF concentrations of methylprednisolone (MP), after a high-dose intravenous
administration (1,500 mg) prescribed to patients presenting acute exacerbation of multiple …

The standard therapy for episodes of severe acute inflammatory demyelinating disease of
the central nervous system is high dose intravenous corticosteroids. A small proportion of …

The efficacy of dexamethasone (DX) and methylprednisolone (MP) at high (HD) and low
(LD) dose in acute multiple sclerosis (MS) relapses was evaluated by a double-blind trial in …